Research

Hormonal

Anti-obesity medications (AOMs) such as GLP-1 receptor agonists do not render lifestyle-based treatments obsolete; rather, they act synergistically by addressing physiological barriers to weight loss, allowing behavioral interventions to focus on optimizing body composition and long-term health maintenance.

Do not stop your lifestyle efforts when starting medication. Use the medication to manage hunger and physiological resistance, then redirect that energy into building fitness, muscle mass, and healthy eating habits. The medication handles the biology; you handle the lifestyle optimization for long-term health.

GoodQualifiesHIGH confidence
In this Perspective, the authors contend that medical approaches impact physiologic pathways to support the success of behavioral approaches. Similarly, behavioral approaches can improve weight loss-adjacent outcomes that are not addressed by medication. Thus, the two approaches are complementary and must coexist if we are to make a significant, population-level impact on the obesity epidemic.
Kristina H. Lewis et al. · Obesity · 2023

Why this rating

Based on a perspective article citing multiple RCTs (SURMOUNT, STEP 1, STEP 3) and clinical guidelines, though it is not a primary trial itself.

Source

Game changers: do new medications make lifestyle‐based treatment of obesity obsolete?

Kristina H. Lewis et al. · Obesity · 2023

DOI 10.1002/oby.23962

narrative_reviewCited 17×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →